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ABSTRACT
Objectives: To estimate the incidence and risk factors
for gastroenteritis-related hospitalisations in older
adults.
Design: Longitudinal cohort study.
Participants: The 45 and Up Study is a large-scale
Australian prospective study of adults aged ≥45 years
(mean 62.7 years) at recruitment in 2006–2009. Self-
reported demographic, health and dietary information
at recruitment from 265 440 participants were linked to
infectious gastroenteritis hospitalisation data.
Outcome measures: We estimated the incidence of
hospitalisation for infectious gastroenteritis, and
calculated HRs using Cox regression, adjusting for
sociodemographic, health and behavioural variables,
with age as the underlying time variable.
Results: There were 6077 incident infectious
gastroenteritis admissions over 1 111 000 person-
years. Incidence increased exponentially with
increasing age; from 2.4 per 1000 (95% CI 2.2 to 2.5)
in individuals aged 45–54 years to 9.5 per 1000 (95%
CI 9.2 to 9.8) in those aged 65+ years. After
adjustment, hospitalisation due to infectious
gastroenteritis was significantly more common in those
reporting use of proton pump inhibitors (HR 1.6, 95%
CI 1.5 to 1.7), and those with poorer self-rated health
(HR 4.2, 95% CI 3.6 to 4.9).
Conclusions: Infectious gastroenteritis results in
hospitalisation of approximately 1% of people
≥65 years old each year. Early recognition and
supportive treatment of diarrhoea in older patients with
poorer self-rated health may prevent subsequent
hospitalisation.
INTRODUCTION
Gastroenteritis is one of the most common
infectious diseases among humans and is a
major cause of mortality in low-income and
middle-income countries, particularly among
children aged <5 years.1 By contrast, the
highest rates of mortality due to gastroenter-
itis in high-income countries occur in the
elderly,2 particularly people aged ≥75 years.3
The elderly are potentially at higher risk of
some enteric infections, due to decreased
gastric acidity, intestinal motility disorders,
and a compromised immune system.4 5
Despite this, the incidence of gastroenteritis
in the elderly living in the community is
lowest of any age group, with one Australian
study estimating the incidence of people
≥65 years old at 0.33 (95% CI 0.24 to 0.42)
episodes per person per year.6
However, older people may experience
more severe symptoms and be more likely to
require hospitalisation than younger
people.6 In Australia, people aged ≥65 years
old were hospitalised with all-cause gastro-
enteritis at a rate of 20.2 per 1000 population
annually between 2009 and 2010.7 In the
USA, hospitalisation due to all-cause gastro-
enteritis increased by ≥50% in all adults and
elder age groups between 1996 and 2007,
with norovirus estimated to be a signiﬁcant
contributor to the high rates among the
elderly.8 Furthermore, the total healthcare
costs for gastroenteritis requiring hospitalisa-
tion are three times higher per adult patient
compared with a child, due to increasing
length of hospital stay and more common
presentation with severe symptoms and
complications.9
Hospitalisation due to infectious gastro-
enteritis imposes a signiﬁcant burden on the
Strengths and limitations of this study
▪ A large population-based cohort study examining
risk factors for hospitalisation due to gastro-
enteritis, with record linkage to multiple
databases.
▪ Prospectively collected data on a range of poten-
tial risk factors and confounders, allowing ana-
lysis of multiple variables.
▪ Self-reported exposure assessment at the
recruitment.
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health system in industrialised countries.10 However, risk
factors among older adults have not been well described.
In this study, our objective was to estimate age-speciﬁc
rates of hospitalisation due to infectious gastroenteritis,
along with risk factors, in a large cohort of Australian
adults.
METHOD
Study population
The Sax Institute’s 45 and Up Study is a population-
based cohort which recruited over 267 000 residents in
the Australian state of New South Wales (NSW) who
were aged 45 years and over between January 2006 and
December 2008. Details of the study methods are pub-
lished elsewhere.11 Study participants were randomly
selected from the national health insurance database
(Medicare), and there was oversampling of those living
in rural regions and those aged over 80 years.
Participants completed a questionnaire at recruitment
where they provided information on sociodemographics,
lifestyle, dietary habits and their health (see https://
www.saxinstitute.org.au/our-work/45-up-study/
questionnaires/), and agreed to have their data linked
to other administrative health records.
Questionnaire data from study participants were
linked to the NSW Admitted Patient Data Collection
(APDC) to identify hospitalisations due to infectious
gastroenteritis, and the NSW Register of Births, Deaths
and Marriages (RBDM) for deaths. The NSW APDC
records demographic and episode-related information
for all patient admissions to NSW hospitals, and includes
the principal diagnosis responsible for the admission, up
to 54 additional diagnoses contributing to the admis-
sion, and the date of admission. Clinical information is
coded using the International Classiﬁcation of Disease
V.10 Australian modiﬁcation (ICD-10-AM).12 The NSW
RBDM includes a record of all deaths in NSW and the
date of death. Information on cause of death was not
available at the time of analysis. We had complete APDC
and RBDM records until 30 June 2012. The 45 and Up
Study participant data, APDC and RBDM were linked
independently of the study investigators by the NSW
Centre for Health Record Linkage using personal infor-
mation such as name, date of birth and sex, with false-
positive and false-negative rates of <0.5% and <0.1%,
respectively.13
Case definition
Participants were deﬁned as having an incident hospital-
isation with infectious gastroenteritis if they had a linked
APDC record where the principal or a secondary diag-
nosis was coded with an ICD-10-AM code for either diar-
rhoea of determined aetiology-bacterial (A00-A05),
parasitic (A06-A07), viral (A08) or undetermined
aetiology-presumed infectious disease (A09), and the
admission occurred following recruitment.
A gastroenteritis complication was deﬁned if cases also
had coded in their linked APDC record either ﬂuid,
electrolyte and acid–base disorders (ICD-10-AM E87
excluding ﬂuid overload E87.7); shock (R57, excluding
cardiogenic shock R57.0) or septicaemia (A41.9).
Statistical analysis
Participants who had a linked hospitalisation record for
gastroenteritis in the 30 days prior to recruitment were
excluded, as we wanted to exclude the possibility that
any admissions due to gastroenteritis immediately follow-
ing recruitment may be part of that same episode. To
minimise the impact of pre-existing illness that may pre-
dispose individuals to infectious gastroenteritis, partici-
pants were also excluded if they had a linked
hospitalisation record with a principal diagnosis code
for any of the following: chronic bowel problems (non-
infective enteritis and colitis K50-K52, irritable bowel syn-
drome K58), immunosuppressive disorders (D80-D89),
or cancer (C00-C97) in the 5 years prior to study entry.
Follow-up was calculated from the date of recruitment to
the ﬁrst date of admission for gastroenteritis, death or
the end of database follow-up (30 June 2012), whichever
came ﬁrst. Incident gastroenteritis hospitalisation rates
were calculated according to age (45–54, 55–64, 65–74,
75–84 or ≥85 years), sex, annual household income
(<$A20 000, $A20 000–$A29 999, $A30 000–$A39 999,
$A40 000–$A49 999, $A50 000–$A69 999, $A70 000 or
more per year, or unknown), and region of residence
(cities, inner regional or outer regional/remote/very
remote) based on the Accessibility/Remoteness Index of
Australia.14
HRs for hospitalisations due to gastroenteritis by socio-
demographic, behavioural and health status variables
were estimated using Cox proportional hazards models
with age as the underlying time variable.15 Regression
models were adjusted for attained age (as this was the
underlying time variable) and sex. Models were then
adjusted for additional variables, including annual
household income, region of residence, education (3
categories: university degree or higher, no university
degree, or unknown), health status variables including
self-rated health (excellent, very good, good, fair, poor
or unknown), and body mass index (BMI: underweight
(<18.5 kg/m2), normal (18.5–24.99 kg/m2), overweight
(25–29.99 kg/m2), obese (≥30 kg/m2) or unknown),
smoking (current, past, never or unknown), alcohol
(none, 1–2 alcoholic drinks per day, >2 alcoholic drinks
per day or unknown) and factors which have been previ-
ously identiﬁed as risk factors for gastroenteritis, includ-
ing living in aged care facilities (yes, no or unknown),
proton pump inhibitors (PPIs) usage (yes, no), fre-
quency of chicken/poultry intake (none, at least once
per week or unknown), frequency of seafood intake
(none, at least once per week or unknown), egg con-
sumption (ever, never), and fruit and vegetable intake
(low, adequate or unknown). Fruit and vegetable intake
was categorised as ‘low’ if fruit intake was less than two
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servings daily, or vegetable intake was less than ﬁve ser-
vings daily, and ‘adequate’ if fruit intake was at least two
servings daily and vegetable intake at least ﬁve servings
daily. Participants were classiﬁed as using PPIs if they
answered yes to the question ‘Have you taken any medi-
cations, vitamins or supplements for most of the last 4
weeks?’, and crossed out either ‘Nexium’, ‘Somac’ or
‘Losec, Acimax omeprazole’ in the baseline question-
naire. Participants were classiﬁed as not using PPIs if
they answered ‘no’ to the above question, or answered
‘yes’ to the above question but did not cross out any one
of the above medications.
Missing values for variables were coded as separate cat-
egories in the model. The proportionality assumption
was examined by plotting the Schoenfeld residuals
against the time variable in each model.16 Where this
assumption was violated, we stratiﬁed exposure variables
and compared ﬁndings under the two models.
Sensitivity analyses were conducted by deﬁning cases as
only those with a principal hospital diagnosis of infec-
tious gastroenteritis, and also including participants with
a hospitalisation for chronic bowel problems, immuno-
suppressive disorders and cancer as a principal diagno-
sis, before recruitment. All analyses were carried out
using STATAV.12.1.
RESULT
After excluding participants with a linked infectious
gastroenteritis hospitalisation record 30 days prior to
recruitment (n=45), participants with prior hospitalisa-
tions for speciﬁc illnesses associated with hospitalisations
due to gastroenteritis (n=706), and conﬁrmed linkage
errors (n=44), there were 265 440 participants in the
analysis, yielding a total of 1 111 223 years of follow-up
(median 3.9 years per person). The mean age of study
participants at recruitment was 62.7 years (SD 11.2), and
53.6% were women.
There were 6077 (2.3%) participants with at least one
linked incident infectious gastroenteritis hospitalisation
record during follow-up, of which 53.7% (3261/6077)
had infectious gastroenteritis as the primary reason for
admission (see online supplementary table S1). Among
the 6077 participants with hospitalisation due to
incident-infectious gastroenteritis, 58.6% (3560/6077)
were referred to the hospital from the emergency
department, and 26.8% (1631/6077) from a medical prac-
titioner. The remaining cases were referred from a range
of other sources, including community health, residential
care and other hospitals. The mean length of hospital stay
for the ﬁrst hospitalisation among those 6077 participants
admitted was 7.5 (SD 17.4) days; median length 3 days.
Complications of gastroenteritis were reported in 11.0%
(667/6077) of the hospitalisations due to gastroenteritis.
Both the length of stay and the proportion with complica-
tions increased with increasing age (table 1). Among
cases, 2.6% (160/6077) of the patients died within 30 days
of hospital admission. Participants aged ≥65 years
accounted for the majority of these deaths (90.6%,
n=145) (table 1).
The crude incidence of hospitalisations due to gastro-
enteritis in the cohort was 5.5 per 1000 person-years (95%
CI 5.3 to 5.6), which differed by age, sex, household
income and region of residence. Incidence rose from 2.4
hospitalisations per 1000 (95% CI 2.2 to 2.5) person-years
in individuals aged 45–54 years to 21.8 per 1000 (95% CI
20.2 to 23.6) in those aged 85+ years (p<0.001 for linear
trend) (table 2). The rate of hospitalisations due to gastro-
enteritis was higher in women than in men (5.8 and 5.0
per 1000 person-years, respectively), but for both sexes,
hospitalisation rates increased with decreasing household
income (p<0.001). Rates were also greater among those
living in cities than in other regions (6.1, 4.9 and 5.1 per
1000 person-years, respectively, in those living in cities,
inner regional, outer regional; p=0.01) (table 2).
After full adjustment, participant sex, self-rated health,
BMI and use of PPIs remained signiﬁcantly associated
with hospitalisation due to gastroenteritis (ﬁgure 1).
The adjusted HRs (aHR) increased signiﬁcantly with
poorer self-reported health with risks >300% greater for
those with poor versus those with excellent health (aHR
4.18, 95% CI 3.61 to 4.84). Hospitalisation due to infec-
tious gastroenteritis was signiﬁcantly more common in
those reporting PPIs use (aHR 1.57, 95% CI 1.48 to
1.66). Compared with participants with a healthy BMI,
the risk was signiﬁcantly higher in the underweight
(aHR 1.22, 95% CI 1.02 to 1.47) and the obese (aHR
1.08, 95% CI 1.01 to 1.15). We did not observe signiﬁ-
cant associations between hospitalisations due to gastro-
enteritis and food consumption, including fruit and
vegetable intake, chicken/poultry intake, egg consump-
tion and seafood consumption (ﬁgure 1).
Table 1 Proportion of total complications of gastroenteritis, and mean length of hospital stay by age group, 45 and Up Study
Age group (years) Complications Cases
Complications/
cases (%)
Mean length of hospital
stay (days) (SD)
Death within 30 days
of admission
45–54 56 785 7.1 4.0 (11.9) 4 (2.5)
55–64 118 1347 8.8 5.8 (15.3) 11 (6.9)
65–74 134 1484 9.1 6.2 (10.2) 25 (15.6)
75–84 260 1829 14.2 9.6 (15.8) 81 (50.6)
≥85 99 632 15.7 12.5 (34.5) 39 (24.4)
Total 667 6077 11.0 7.5 (17.4) 160
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Examining PPIs usage, we identiﬁed potential con-
cerns with the proportionality assumption, however, a
comparison of ﬁndings with a stratiﬁed version of the
variable reassured us that PPIs usage could be included
in the ﬁnal Cox model unaltered (data not shown).
There were 3261 hospitalisations due to gastroenter-
itis, where a gastrointestinal infection code occurred in
the principal hospital diagnosis ﬁeld (see online supple-
mentary table S1). Overall results were generally similar
to the broader deﬁnition, with the rates of hospitalisa-
tions due to gastroenteritis increasing with increasing
age (p<0.001 for linear trend). Male sex was signiﬁcantly
related to a reduced risk (aHR 0.75, 95% CI 0.69 to
0.81). Poorer self-rated health (aHR 3.45, 95% CI 2.80
to 4.26), obesity (1.12, 95% CI 1.02 to 1.22) and PPIs
use (1.74, 95% CI 1.61 to 1.89) were all related to an
increased risk of hospitalisations due to gastroenteritis.
The sensitivity analysis, including cases with a linked
record of hospital admission with pre-existing illness,
showed little change in the HRs (n=266 146; 6783 inci-
dent hospitalisations due to gastroenteritis since base-
line; see online supplementary table S2).
DISCUSSION
In this large population-based prospective study, hospi-
talisation due to infectious gastroenteritis was extremely
common. We estimate that 1% of people aged
≥65 years old were hospitalised annually with gastro-
enteritis, and accounted for more than two-thirds of
gastroenteritis-related complications. The incidence
and length of hospital stay increased dramatically with
increasing age. After adjustment, females, adults with
poor general health, and those taking PPIs had a
greater risk of being hospitalised with gastroenteritis.
The high rate of hospitalisations due to gastroenteritis
in the elderly is consistent with increased rates of hospi-
talisation for infectious disease in this age group,7 17
although the rate in people aged ≥65 years old was
lower than a previous study examining hospitalisations
due to gastroenteritis nationally due to all causes.7 This
may reﬂect differences in study design and case deﬁni-
tions. In particular, the national study included admis-
sion codes for conditions that were not necessarily
infectious in nature, whereas, we attempted to include
only infectious causes. The trend of increasing hospitali-
sations with age in our study is likely to be due to
greater severity of illness in older patients,18 and the
increasing likelihood of severe consequences, such as
dehydration, electrolyte imbalance and exacerbation of
chronic conditions.19
Differences by sex were noted for hospitalisations due
to gastroenteritis in all age groups. The pattern was pre-
viously reported in a US study, which used nationally
representative data to investigate the trend of hospitalisa-
tions due to infectious disease for all ages.20 One pos-
sible explanation for the higher rate in females may be
inadequate family support and social care for older
women, possibly resulting in greater use of hospital ser-
vices. In this study, we observed a higher proportion of
Table 2 Crude incidence of hospitalisations due to gastroenteritis by characteristics in mid-age and older adults, the 45 and
Up Study
Characteristics Population Cases/person-years
Incidence (95% CI)/1000
person-years p Value
Age group (years) <0.001
45–54 77 669 785/332 330 2.4 (2.2 to 2.5)
55–64 85 487 1347/363 217 3.7 (3.5 to 3.9)
65–74 57 678 1484/241 404 6.1 (5.8 to 6.5)
75–84 36 470 1829/145 330 12.6 (12.0 to 13.2)
≥85 8136 632/28 941 21.8 (20.2 to 23.6)
Sex <0.001
Female 142 313 3479/596 317 5.8 (5.6 to 6.0)
Male 123 127 2598/514 905 5.0 (4.9 to 5.2)
Household income ($A/year) <0.001
<$A20 000 52 051 1855/214 088 8.7 (8.3 to 9.1)
$A20 000–$A29 999 25 403 655/106 717 6.1 (5.7 to 6.6)
$A30 000–$A39 999 21 005 433/88 693 4.9 (4.4 to 5.4)
$A40 000–$A49 999 19 156 324/80 931 4.0 (3.6 to 4.5)
$A50 000–$A69 999 27 751 397/117 755 3.4 (3.1 to 3.7)
$A70 000 or more 62 605 655/263 829 2.5 (2.3 to 2.7)
Unknown 57 469 1758/239 205 7.4 (7.0 to 7.7)
Region of residence 0.01
Cities 119 449 3012/497 142 6.1 (5.8 to 6.3)
Inner regional 93 299 1932/392 057 4.9 (4.7 to 5.2)
Outer regional/remote/very remote 52 692 1133/222 023 5.1 (4.8 to 5.4)
Total 265 440 6077/1 111 223 5.5 (5.3 to 5.6)
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female cases (62%) having an additional diagnosis
coded with an ICD-10-AM for living alone (Z60.2), inad-
equate family support (Z63.2) and absence of a family
member (Z63.3), than male cases (38%) at the time of
admission, which may indicate an inadequate care of
female patients in our study.
Self-rated health has previously been reported as a
signiﬁcant predictor of severe health outcomes, such
as mortality.21 Although mortality remains the stron-
gest biological indicator of ill-health, disease-related
hospitalisation captures the direct burden of illness. In
our study, participants’ responses to questions about
self-rated health demonstrated a strong association
with hospitalisations due to gastroenteritis. Consequently,
poor self-rated health may serve as a useful marker for
people at higher risk of hospitalisation who present to
family physicians with gastroenteritis. Similarly, people
with a very high or very low BMI were at higher risk of
hospitalisation with gastroenteritis. These ﬁndings high-
light the importance of general health in affecting hospi-
talisation with gastrointestinal infection in older adults.
We identiﬁed an association between PPIs use and
hospitalisation with gastroenteritis, which has been con-
sistently shown in previous studies investigating risk
Figure 1 Associations between various baseline characteristics and incident infectious gastroenteritis hospitalisations, the 45
and Up Study (BMI, body mass index).
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factors for gastrointestinal infections.22 23 Treatment
with PPIs lowers gastric acidity, which is a ﬁrst line of
defence against ingested pathogens, leading to bacterial
colonisation, thus increasing an individual’s susceptibil-
ity to enteric infection.24 A recent study examining the
incidence of Salmonella and Campylobacter infection in
patients prescribed PPIs argued that such people were
already at higher underlying risk of enteric infection
before prescription.25 In our study, PPIs use was self-
reported at recruitment, and was signiﬁcantly associated
with later hospitalisation for gastroenteritis even after
adjusting for self-rated health at baseline. Although our
study was insufﬁcient to establish a causal relationship,
this adds to the evidence that PPIs are associated with
hospitalisation involving enteric infection.
We investigated the possible association between food
consumption history and the risk of gastroenteritis, but
did not observe any association between frequency of
fruit and vegetable intake, chicken and poultry, seafood
or eggs, and risk of hospitalisations due to infectious
gastroenteritis. This may be due to the nature of the
baseline questionnaire that did not collect detailed
dietary information of participants. For example, in the
questionnaire, participants were only asked if they ever
eat eggs, and did not collect information on frequency
of egg consumption. Additionally, our study captures
cases of gastroenteritis due to a range of aetiological
agents, so it is not surprising that foods were not import-
ant risk factors. Campylobacter spp and Salmonella spp are
commonly found in adult patients hospitalised with
infectious gastroenteritis,26 although viral enteritis has
also been identiﬁed as a key cause of seasonal increases
in hospitalisation among the elderly.27
Our study has several limitations that may inﬂuence
the interpretation of results. First, risk factors were
reported at the time of recruitment, and may have
changed between recruitment and hospitalisation.
Second, exposure assessment was based on self-report.
Dietary intake can be difﬁcult to measure, despite self-
report being reasonably reliable for some factors.28 29
However, a validation study involving the short questions
related to diet used in the 45 and Up Study question-
naire has shown them to be reproducible over time.30
Third, the 45 and Up study cohort, while including
about 1 in 10 adults in the age range in NSW, is likely to
be more health conscious than the general NSW popula-
tion, hence, the rates of hospitalisations due to gastro-
enteritis may be underestimated, although this would be
unlikely to affect within-cohort comparisons, such as the
estimates of HRs.31
CONCLUSION
Our results highlight a substantial burden to the health-
care system from gastroenteritis in an aging population.
Future efforts should focus on deﬁning and improving
preventive measures for hospitalisations due to gastro-
enteritis among the elderly. Early recognition and
supportive treatment of diarrhoea in older patients with
poorer self-rated health may prevent subsequent hospi-
talisation. Additionally, further research is required to
examine if PPIs use results in excess hospitalisations due
to gastroenteritis and speciﬁc enteric infections, as it is a
potentially modiﬁable risk factor.
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